NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
+12.99%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$116M
AUM Growth
+$116M
(+5.2%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
96.01%
Holding
17
New
4
Increased
3
Reduced
2
Closed
3
Top Buys
| 1 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$2.49M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$1.41M |
| 3 |
VistaGen Therapeutics
VTGN
|
$1.38M |
| 4 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$1.04M |
| 5 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$725K |
Top Sells
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$3.79M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$2.98M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$1.42M |
| 4 |
Incyte
INCY
|
$1.16M |
| 5 |
Dynavax Technologies
DVAX
|
$600K |
Sector Composition
| 1 | Healthcare | 94.43% |
